Global Information, Inc.
日商環球訊息有限公司
網站導覽
首頁 產業/市場分類 出版商一覽 商品目錄 國際會議·研討會 GII簡介 聯絡我們
產業/市場分類
生物科技
抗體和免疫
生物材料
基因治療學和RNAi
再生醫學
分子標靶治療學
以基因為基之藥物開發
生物標記
生技設備
個人化醫學
其他的市場分類
有興趣參與全球國際會議(展示會)嗎?
英文調查報告書

歐洲整型外科用生物材料市場

European Markets for Orthopedic Biomaterials 2009

出版商 iData Research Inc. 聯絡我們
出版日期 2009/04 內容資訊 545 Pages
商品編碼 78468
價格 US $ 10,995 ~ Price List
US $ 10,995 Hard Copy
US $ 11,495 PDF by E-mail (Single User License)
US $ 13,995 PDF by E-mail (Corporate License)
如何訂購
本頁所標示之售價為不含購買者所在地消費稅之未稅價格，相關消費稅金將另行加至交易金額中
 aaaaaaa
PDF by E-Mail
2個工作天後到貨
Hard Copy/CD-ROM
約5個工作天左右
TOC
此出版品為英文撰寫

Abstract

In 2008, the combined European biomaterial market was worth €271.4 million. This includes hyaluronic acid viscosupplements, bone graft substitutes, BMP growth factors, autologous chondrocyte implantation and platelet/bone marrow concentration systems. Within this report, the various bone grafting materials are examined, including autografted bone, allografts, demineralized bone and synthetic bone substitutes. The market across Europe is highly dependant on regulation, reimbursement and regional supply issues. Each of these has shaped the products of preference in each country, and understanding how they interact is a vital importance in providing orthopedic biomaterials to the European market. The European market encompasses Germany, France, Italy, United Kingdom (U.K.), Spain, Benelux (Belgium, the Netherlands, and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Switzerland, Austria, and Portugal.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1 TOTAL EUROPEAN ORTHOPEDIC BIOMATERIAL MARKET
  • 1.2 AUTOGRAFTED BONE PROCEDURES
  • 1.3 BONE GRAFT SUBSTITUTE WASTAGE
  • 1.4 ALLOGRAFT, DBM AND SYNTHETIC BONE GRAFT SUBSTITUTE MARKET
  • 1.5 HYALURONIC VISCOSUPPLEMENT MARKET
  • 1.6 AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET
  • 1.7 BMP GROWTH FACTOR MARKET
  • 1.8 PLATELET AND BONE MARROW CONCENTRATION MARKET
  • 1.9 LEADING COMPETITORS

RESEARCH METHODOLOGY

  • 2.1 RESEARCH SCOPE
  • 2.2 IDATA' S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Survey Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecasting
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

OVERVIEW OF EUROPEAN ORTHOPEDIC BIOMATERIALS

  • 3.1 INTRODUCTION
  • 3.2 OVERVIEW
    • 3.2.1 Growth Factors
    • 3.2.2 Bone Graft Substitutes
    • 3.2.3 Hyaluronic Acid Viscosupplementation
    • 3.2.4 Autologous Chondrocyte Implantation (ACI)
    • 3.2.5 Platelet and Bone Marrow Concentration
  • 3.3 CURRENCY EXCHANGE RATE
  • 3.4 MARKET ANALYSIS AND FORECAST
    • 3.4.1 Analysis and Forecast of Total Market
  • 3.5 MARKET DRIVERS
  • 3.6 MARKET LIMITERS
  • 3.7 COMPETITIVE ANALYSIS
    • 3.7.1 Leading Competitors
    • 3.7.2 Market Concentration
  • 3.8 MERGERS AND ACQUISITIONS

COUNTRY PROFILES

  • 4.1 INTRODUCTION
    • 4.1.1 Population
    • 4.1.2 GDP per Capita
    • 4.1.3 Procedures
    • 4.1.4 Price Index
    • 4.1.5 Germany
  • 4.2 FRANCE
  • 4.3 UNITED KINGDOM
  • 4.4 SPAIN
  • 4.5 ITALY
  • 4.6 BENELUX
  • 4.7 SCANDINAVIA
  • 4.8 SWITZERLAND
  • 4.9 AUSTRIA
  • 4.10 PORTUGAL
  • 4.11 GREECE

BONE GRAFT SUBSTITUTE MARKET

  • 5.1 TOTAL MARKET
    • 5.1.1 Introduction
    • 5.1.2 Overview
    • 5.1.3 Volume Usage and Pricing
      • 5.1.3.1 Wastage
      • 5.1.3.2 Volumes Represented per Procedure
    • 5.1.4 Autograft Procedures
    • 5.1.5 Spine Fusion Procedures
    • 5.1.6 Market Analysis and Forecast
      • 5.1.6.1 Total Commercial Bone Graft Substitute Market
      • 5.1.6.2 Total Utilized Bone Graft Substitute Market
      • 5.1.6.3 Total Spine Market by Allograft, DBM and Synthetic Materials
      • 5.1.6.4 Cervical Spine Market by Allograft, DBM and Synthetic Materials
      • 5.1.6.5 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
      • 5.1.6.6 Extremity Market by Allograft, DBM and Synthetic Materials
      • 5.1.6.7 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
    • 5.1.7 Market Drivers and Limiters
      • 5.1.7.1 Market Drivers
      • 5.1.7.2 Market Limiters
    • 5.1.8 Competitive Analysis
      • 5.1.8.1 Bone Graft Substitute Market
      • 5.1.8.2 Spinal Fusion Market Leading Competitors
  • 5.2 GERMANY
    • 5.2.1 Autograft Procedures
    • 5.2.2 Spine Fusion Procedures
    • 5.2.3 Market Forecast and Analysis
      • 5.2.3.1 Total Commercial Bone Graft Substitute Market
      • 5.2.3.2 Total Utilized Bone Graft Substitute Market
      • 5.2.3.3 Total Market by Allograft, DBM and Synthetic Materials
      • 5.2.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
      • 5.2.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
      • 5.2.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
      • 5.2.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
      • 5.2.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
    • 5.2.4 Market Drivers and Limiters
      • 5.2.4.1 Market Drivers
      • 5.2.4.2 Market Limiters
    • 5.2.5 France
    • 5.2.6 Autograft Procedures
    • 5.2.7 Spine Fusion Procedures
    • 5.2.8 Market Forecast and Analysis
      • 5.2.8.1 Total Commercial Bone Graft Substitute Market
      • 5.2.8.2 Total Utilized Bone Graft Substitute Market
      • 5.2.8.3 Total Market by Allograft, DBM and Synthetic Materials
      • 5.2.8.4 Total Spine Market by Allograft, DBM and Synthetic Materials
      • 5.2.8.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
      • 5.2.8.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
      • 5.2.8.7 Extremity Market by Allograft, DBM and Synthetic Materials
      • 5.2.8.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
    • 5.2.9 Market Drivers and Limiters
    • 5.2.9.1 Market Drivers
    • 5.2.9.2 Market Limiters
  • 5.3 UNITED KINGDOM
    • 5.3.1 Autograft Procedures
    • 5.3.2 Spine Fusion Procedures
    • 5.3.3 Market Forecast and Analysis
      • 5.3.3.1 Total Commercial Bone Graft Substitute Market
      • 5.3.3.2 Total Utilized Bone Graft Substitute Market
      • 5.3.3.3 Total Market by Allograft, DBM and Synthetic Materials
      • 5.3.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
      • 5.3.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
      • 5.3.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
      • 5.3.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
      • 5.3.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
    • 5.3.4 Market Drivers and Limiters
      • 5.3.4.1 Market Drivers
      • 5.3.4.2 Market Limiters
  • 5.4 SPAIN
    • 5.4.1 Autograft Procedures
    • 5.4.2 Spine Fusion Procedures
    • 5.4.3 Market Forecast and Analysis
      • 5.4.3.1 Total Commercial Bone Graft Substitute Market
      • 5.4.3.2 Total Utilized Bone Graft Substitute Market
      • 5.4.3.3 Total Market by Allograft, DBM and Synthetic Materials
      • 5.4.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
      • 5.4.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
      • 5.4.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
      • 5.4.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
      • 5.4.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
    • 5.4.4 Market Drivers and Limiters
      • 5.4.4.1 Market Drivers
      • 5.4.4.2 Market Limiters
  • 5.5 ITALY
    • 5.5.1 Autograft Procedures
    • 5.5.2 Spine Fusion Procedures
    • 5.5.3 Market Forecast and Analysis
      • 5.5.3.1 Total Commercial Bone Graft Substitute Market
      • 5.5.3.2 Total Utilized Bone Graft Substitute Market
      • 5.5.3.3 Total Market by Allograft, DBM and Synthetic Materials
      • 5.5.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
      • 5.5.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
      • 5.5.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
      • 5.5.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
      • 5.5.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
    • 5.5.4 Market Drivers and Limiters
      • 5.5.4.1 Market Drivers
      • 5.5.4.2 Market Limiters
  • 5.6 BENELUX
    • 5.6.1 Autograft Procedures
    • 5.6.2 Spine Fusion Procedures
    • 5.6.3 Market Forecast and Analysis
      • 5.6.3.1 Total Commercial Bone Graft Substitute Market
      • 5.6.3.2 Total Utilized Bone Graft Substitute Market
      • 5.6.3.3 Total Market by Allograft, DBM and Synthetic Materials
      • 5.6.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
      • 5.6.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
      • 5.6.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
      • 5.6.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
      • 5.6.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
    • 5.6.4 Market Drivers and Limiters
      • 5.6.4.1 Market Drivers
      • 5.6.4.2 Market Limiters
  • 5.7 SCANDINAVIA
    • 5.7.1 Autograft Procedures
    • 5.7.2 Spine Fusion Procedures
    • 5.7.3 Market Forecast and Analysis
      • 5.7.3.1 Total Commercial Bone Graft Substitute Market
      • 5.7.3.2 Total Utilized Bone Graft Substitute Market
      • 5.7.3.3 Total Market by Allograft, DBM and Synthetic Materials
      • 5.7.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
      • 5.7.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
      • 5.7.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
      • 5.7.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
      • 5.7.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
    • 5.7.4 Market Drivers and Limiters
    • 5.7.4.1 Market Drivers
    • 5.7.4.2 Market Limiters
  • 5.8 SWITZERLAND
    • 5.8.1 Autograft Procedures
    • 5.8.2 Spine Fusion Procedures
    • 5.8.3 Market Forecast and Analysis
      • 5.8.3.1 Total Commercial Bone Graft Substitute Market
      • 5.8.3.2 Total Utilized Bone Graft Substitute Market
      • 5.8.3.3 Total Market by Allograft, DBM and Synthetic Materials
      • 5.8.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
    • 5.10.4 Market Drivers and Limiters
      • 5.10.4.1 Market Drivers
      • 5.10.4.2 Market Limiters
  • 5.11 GREECE
    • 5.11.1 Autograft Procedures
    • 5.11.2 Spine Fusion Procedures
    • 5.11.3 Market Forecast and Analysis
      • 5.11.3.1 Total Commercial Bone Graft Substitute Market
      • 5.11.3.2 Total Utilized Bone Graft Substitute Market
      • 5.11.3.3 Total Market by Allograft, DBM and Synthetic Materials
      • 5.11.3.4 Total Spine Market by Allograft, DBM and Synthetic Materials
      • 5.11.3.5 Cervical Spine Market by Allograft, DBM and Synthetic Materials
      • 5.11.3.6 Thoracolumbar Spine Market by Allograft, DBM and Synthetic Materials
      • 5.11.3.7 Extremity Market by Allograft, DBM and Synthetic Materials
      • 5.11.3.8 Craniomaxillofacial Market by Allograft, DBM and Synthetic Materials
    • 5.11.4 Market Drivers and Limiters
      • 5.11.4.1 Market Drivers
      • 5.11.4.2 Market Limiters

BMP GROWTH FACTOR MARKET

  • 6.1 INTRODUCTION
    • 6.1.1 Overview
    • 6.1.2 Potential Complications
    • 6.1.3 Future Indications
  • 6.2 MARKET ANALYSIS AND FORECAST
  • 6.3 MARKET DRIVERS AND LIMITERS
    • 6.3.1.1 Market Drivers
    • 6.3.1.2 Market Limiters
  • 6.4 COMPETITIVE ANALYSIS

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • 7.1 INTRODUCTION
    • 7.1.1 Three-Injection Cycle Products
    • 7.1.2 Five-Injection Cycle Products
    • 7.1.3 Single-Injection Cycle Products
  • 7.2 MARKET ANALYSIS AND FORECAST
    • 7.2.1 Total Market
    • 7.2.2 Single-Cycle
    • 7.2.3 Three-Cycle
    • 7.2.4 Five-Cycle
    • 7.2.5 Hyaluronic Acid Viscosupplementation Injections per Country
  • 7.3 MARKET DRIVERS AND LIMITERS
    • 7.3.1 Market Drivers
    • 7.3.2 Market Limiters
  • 7.4 COMPETITIVE ANALYSIS

AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET

  • 8.1 INTRODUCTION
  • 8.2 OVERVIEW
  • 8.3 MARKET FORECAST AND ANALYSIS
  • 8.4 MARKET DRIVERS AND LIMITERS
    • 8.4.1.1 Market Drivers
    • 8.4.1.2 Market Limiters
  • 8.5 COMPETITIVE ANALYSIS

PLATELET AND BONE MARROW CONCENTRATION MARKET

  • 9.1 INTRODUCTION
  • 9.2 OVERVIEW
    • 9.2.1 Platelet Rich Plasma
    • 9.2.2 Bone Marrow Aspirate
  • 9.3 MARKET ANALYSIS AND FORECAST
    • 9.3.1.1 Total Cell Concentration Market
    • 9.3.1.2 Platelet Concentration
    • 9.3.1.3 Bone Marrow Concentration
  • 9.4 MARKET DRIVERS AND LIMITERS
    • 9.4.1.1 Market Drivers
    • 9.4.1.2 Market Limiters
  • 9.5 COMPETITIVE ANALYSIS

ABBREVIATIONS

APPENDIX 1: JOINT RECONSTRUCTION PROCEDURES

LIST OF FIGURES

EXECUTIVE SUMMARY 1

RESEARCH METHODOLOGY 9

OVERVIEW OF EUROPEAN ORTHOPEDIC BIOMATERIALS 20

  • Figure 3-1: Exchange Rate Between Euro and Other Currencies, 2008 23
  • Figure 3-2: Total European Orthopedic Biomaterial Market, Europe, 2005 - 2015 (€) 25
  • Figure 3-3: Total European Orthopedic Biomaterial Market, Europe, 2005 - 2015 (US$) 25
  • Figure 3-4: Market Drivers, Orthopedic Biomaterials Market, Europe, 2008 27
  • Figure 3-5: Market Limiters, Orthopedic Biomaterials Market, Europe, 2008 28
  • Figure 3-6: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2008 30
  • Figure 3-7: Other Notable Competitors, Orthopedic Biomaterial Market, Europe, 2008 31
  • Figure 3-8 Market Concentration, Orthopedic Biomaterials Market, U.S. 2007 33

COUNTRY PROFILES 35

BONE GRAFT SUBSTITUTE MARKET 48

  • Figure 5-1: Total Autograft Procedures, Europe, 2005 - 2015 52
  • Figure 5-2 Spine Fusion Procedures, Europe, 2005 - 2015 53
  • Figure 5-3: Total Bone Graft Substitute Market, Europe, 2005 - 2015 (€) 55
  • Figure 5-4: Total Bone Graft Substitute Market, Europe, 2005 - 2015 (US$) 55
  • Figure 5-5 Total Procedures by Indication, Europe, 2005 - 2015 58
  • Figure 5-6 Total Utilized Market Value by Indication, Europe, 2005 - 2015 (€) 59
  • Figure 5-7 Total Utilized Market Value by Indication, Europe, 2005 - 2015 (US$) 59
  • Figure 5-8: Utilized Bone Graft Substitute Market, Europe, 2005 - 2015 (€) 60
  • Figure 5-9: Utilized Bone Graft Substitute Market, Europe, 2005 - 2015 (US$) 60
  • Figure 5-10: Total Allograft Market, Europe, 2005 - 2015 (€) 62
  • Figure 5-11: Total Allograft Market, Europe, 2005 - 2015 (US$) 62
  • Figure 5-12: Total DBM Market, Europe, 2005 - 2015 (€) 63
  • Figure 5-13: Total DBM Market, Europe, 2005 - 2015 (US$) 63
  • Figure 5-14: Total Synthetic Market, Europe, 2005 - 2015 (€) 64
  • Figure 5-15: Total Synthetic Market, Europe, 2005 - 2015 (US$) 64
  • Figure 5-16: Allograft Spine Market, Europe, 2005 - 2015 (€) 66
  • Figure 5-17: Allograft Spine Market, Europe, 2005 - 2015 (US$) 66
  • Figure 5-18: DBM Spine Market, Europe, 2005 - 2015 (€) 67
  • Figure 5-19: DBM Spine Market, Europe, 2005 - 2015 (US$) 67
  • Figure 5-20: Synthetic Spine Market, Europe, 2005 - 2015 (€) 68
  • Figure 5-21: Synthetic Spine Market, Europe, 2005 - 2015 (US$) 68
  • Figure 5-22: Allograft Cervical Spine Market, Europe, 2005 - 2015 (€) 70
  • Figure 5-23: Allograft Cervical Spine Market, Europe, 2005 - 2015 (US$) 70
  • Figure 5-24: DBM Cervical Spine Market, Europe, 2005 - 2015 (€) 71
  • Figure 5-25: DBM Cervical Spine Market, Europe, 2005 - 2015 (US$) 71
  • Figure 5-26: Synthetic Cervical Spine Market, Europe, 2005 - 2015 (€) 72
  • Figure 5-27: Synthetic Cervical Spine Market, Europe, 2005 - 2015 (US$) 72
  • Figure 5-28: Allograft Thoracolumbar Spine Market, Europe, 2005 - 2015 (€) 74
  • Figure 5-29: Allograft Thoracolumbar Spine Market, Europe, 2005 - 2015 (US$) 74
  • Figure 5-30: DBM Thoracolumbar Spine Market, Europe, 2005 - 2015 (€) 75
  • Figure 5-31: DBM Thoracolumbar Spine Market, Europe, 2005 - 2015 (US$) 75
  • Figure 5-32: Synthetic Thoracolumbar Spine Market, Europe, 2005 - 2015 (€) 76
  • Figure 5-33: Synthetic Thoracolumbar Spine Market, Europe, 2005 - 2015 (US$)76
  • Figure 5-34: Allograft Extremity Market, Europe, 2005 - 2015 (€) 78
  • Figure 5-35: Allograft Extremity Market, Europe, 2005 - 2015 (US$) 78
  • Figure 5-36: DBM Extremity Market, Europe, 2005 - 2015 (€) 79
  • Figure 5-37: DBM Extremity Market, Europe, 2005 - 2015 (US$) 79
  • Figure 5-38: Synthetic Extremity Market, Europe, 2005 - 2015 (€) 80
  • Figure 5-39: Synthetic Extremity Market, Europe, 2005 - 2015 (US$) 80
  • Figure 5-40: Allograft CMF Market, Europe, 2005 - 2015 (€) 82
  • Figure 5-41: Allograft CMF Market, Europe, 2005 - 2015 (US$) 82
  • Figure 5-42: DBM CMF Market, Europe, 2005 - 2015 (€) 83
  • Figure 5-43: DBM CMF Market, Europe, 2005 - 2015 (US$) 83
  • Figure 5-44: Synthetic CMF Market, Europe, 2005 - 2015 (€) 84
  • Figure 5-45: Synthetic CMF Market, Europe, 2005 - 2015 (US$) 84
  • Figure 5-46: Market Drivers and Limiters, Bone Graft Substitute Market, Europe, 2005 - 2015 87
  • Figure 5-47: Leading Competitors, Bone Graft Substitute Market, Europe, 2008 90
  • Figure 5-48: Leading Competitors in Spinal Fusion Market, Europe, 2008 91
  • Figure 5-49: Total Autograft Procedures, Germany, 2005 - 2015 92
  • Figure 5-50 Spine Fusion Procedures, Germany, 2005 - 2015 93
  • Figure 5-51: Total Bone Graft Substitute Market, Germany, 2005 - 2015 (€) 95
  • Figure 5-52: Total Bone Graft Substitute Market, Germany, 2005 - 2015 (US$) 95
  • Figure 5-53 Total Procedures by Indication, Germany, 2005 - 2015 96
  • Figure 5-54 Total Utilized Market Value by Indication, Germany, 2005 - 2015 (€) 97
  • Figure 5-55 Total Utilized Market Value by Indication, Germany, 2005 - 2015 (US$) 97
  • Figure 5-56: Utilized Bone Graft Substitute Market, Germany, 2005 - 2015 (€) 98
  • Figure 5-57: Utilized Bone Graft Substitute Market, Germany, 2005 - 2015 (US$) 98
  • Figure 5-58: Total Allograft Market, Germany, 2005 - 2015 (€) 100
  • Figure 5-59: Total Allograft Market, Germany, 2005 - 2015 (US$) 100
  • Figure 5-60: Total DBM Market, Germany, 2005 - 2015 (€) 101
  • Figure 5-61: Total DBM Market, Germany, 2005 - 2015 (US$) 101
  • Figure 5-62: Total Synthetic Market, Germany, 2005 - 2015 (€) 102
  • Figure 5-63: Total Synthetic Market, Germany, 2005 - 2015 (US$) 102
  • Figure 5-64: Allograft Spine Market, Germany, 2005 - 2015 (€) 104
  • Figure 5-65: Allograft Spine Market, Germany, 2005 - 2015 (US$) 104
  • Figure 5-66: DBM Spine Market, Germany, 2005 - 2015 (€) 105
  • Figure 5-67: DBM Spine Market, Germany, 2005 - 2015 (US$) 105
  • Figure 5-68: Synthetic Spine Market, Germany, 2005 - 2015 (€) 106
  • Figure 5-69: Synthetic Spine Market, Germany, 2005 - 2015 (US$) 106
  • Figure 5-70: Allograft Cervical Spine Market, Germany, 2005 - 2015 (€) 108
  • Figure 5-71: Allograft Cervical Spine Market, Germany, 2005 - 2015 (US$) 108
  • Figure 5-72: DBM Cervical Spine Market, Germany, 2005 - 2015 (€) 109
  • Figure 5-73: DBM Cervical Spine Market, Germany, 2005 - 2015 (US$) 109
  • Figure 5-74: Synthetic Cervical Spine Market, Germany, 2005 - 2015 (€) 110
  • Figure 5-75: Synthetic Cervical Spine Market, Germany, 2005 - 2015 (US$) 110
  • Figure 5-76: Allograft Thoracolumbar Spine Market, Germany, 2005 - 2015 (€) 112
  • Figure 5-77: Allograft Thoracolumbar Spine Market, Germany, 2005 - 2015 (US$) 112
  • Figure 5-78: DBM Thoracolumbar Spine Market, Germany, 2005 - 2015 (€) 113
  • Figure 5-79: DBM Thoracolumbar Spine Market, Germany, 2005 - 2015 (US$) 113
  • Figure 5-80: Synthetic Thoracolumbar Spine Market, Germany, 2005 - 2015 (€)114
  • Figure 5-81: Synthetic Thoracolumbar Spine Market, Germany, 2005 - 2015 (US$) 114
  • Figure 5-82: Allograft Extremity Market, Germany, 2005 - 2015 (€) 116
  • Figure 5-83: Allograft Extremity Market, Germany, 2005 - 2015 (US$) 116
  • Figure 5-84: DBM Extremity Market, Germany, 2005 - 2015 (€) 117
  • Figure 5-85: DBM Extremity Market, Germany, 2005 - 2015 (US$) 117
  • Figure 5-86: Synthetic Extremity Market, Germany, 2005 - 2015 (€) 118
  • Figure 5-87: Synthetic Extremity Market, Germany, 2005 - 2015 (US$) 118
  • Figure 5-88: Allograft CMF Market, Germany, 2005 - 2015 (€) 120
  • Figure 5-89: Allograft CMF Market, Germany, 2005 - 2015 (US$) 120
  • Figure 5-90: DBM CMF Market, Germany, 2005 - 2015 (€) 121
  • Figure 5-91: DBM CMF Market, Germany, 2005 - 2015 (US$) 121
  • Figure 5-92: Synthetic CMF Market, Germany, 2005 - 2015 (€) 122
  • Figure 5-93: Synthetic CMF Market, Germany, 2005 - 2015 (US$) 122
  • Figure 5-94: Market Drivers and Limiters, Germany, Bone Graft Substitute Market, 2005 - 2015 123
  • Figure 5-95: Total Autograft Procedures, France, 2005 - 2015 124
  • Figure 5-96 Spine Fusion Procedures, France, 2005 - 2015 125
  • Figure 5-97: Total Bone Graft Substitute Market, France, 2005 - 2015 (€) 127
  • Figure 5-98: Total Bone Graft Substitute Market, France, 2005 - 2015 (US$) 127
  • Figure 5-99 Total Procedures by Indication, France, 2005 - 2015 128
  • Figure 5-100 Total Utilized Market Value by Indication, France, 2005 - 2015 (€)129
  • Figure 5-101 Total Utilized Market Value by Indication, France, 2005 - 2015 (US$) 129
  • Figure 5-102: Utilized Bone Graft Substitute Market, France, 2005 - 2015 (€) 130
  • Figure 5-103: Utilized Bone Graft Substitute Market, France, 2005 - 2015 (US$)130
  • Figure 5-104: Total Allograft Market, France, 2005 - 2015 (€) 132
  • Figure 5-105: Total Allograft Market, France, 2005 - 2015 (US$) 132
  • Figure 5-106: Total DBM Market, France, 2005 - 2015 (€) 133
  • Figure 5-107: Total DBM Market, France, 2005 - 2015 (US$) 133
  • Figure 5-108: Total Synthetic Market, France, 2005 - 2015 (€) 134
  • Figure 5-109: Total Synthetic Market, France, 2005 - 2015 (US$) 134
  • Figure 5-110: Allograft Spine Market, France, 2005 - 2015 (€) 136
  • Figure 5-111: Allograft Spine Market, France, 2005 - 2015 (US$) 136
  • Figure 5-112: DBM Spine Market, France, 2005 - 2015 (€) 137
  • Figure 5-113: DBM Spine Market, France, 2005 - 2015 (US$) 137
  • Figure 5-114: Synthetic Spine Market, France, 2005 - 2015 (€) 138
  • Figure 5-115: Synthetic Spine Market, France, 2005 - 2015 (US$) 138
  • Figure 5-116: Allograft Cervical Spine Market, France, 2005 - 2015 (€) 140
  • Figure 5-117: Allograft Cervical Spine Market, France, 2005 - 2015 (US$) 140
  • Figure 5-118: DBM Cervical Spine Market, France, 2005 - 2015 (€) 141
  • Figure 5-119: DBM Cervical Spine Market, France, 2005 - 2015 (US$) 141
  • Figure 5-120: Synthetic Cervical Spine Market, France, 2005 - 2015 (€) 142
  • Figure 5-121: Synthetic Cervical Spine Market, France, 2005 - 2015 (US$) 142
  • Figure 5-122: Allograft Thoracolumbar Spine Market, France, 2005 - 2015 (€) 144
  • Figure 5-123: Allograft Thoracolumbar Spine Market, France, 2005 - 2015 (US$)144
  • Figure 5-124: DBM Thoracolumbar Spine Market, France, 2005 - 2015 (€) 145
  • Figure 5-125: DBM Thoracolumbar Spine Market, France, 2005 - 2015 (US$) 145
  • Figure 5-126: Synthetic Thoracolumbar Spine Market, France, 2005 - 2015 (€) 146
  • Figure 5-127: Synthetic Thoracolumbar Spine Market, France, 2005 - 2015 (US$) 146
  • Figure 5-128: Allograft Extremity Market, France, 2005 - 2015 (€) 148
  • Figure 5-129: Allograft Extremity Market, France, 2005 - 2015 (US$) 148
  • Figure 5-130: DBM Extremity Market, France, 2005 - 2015 (€) 149
  • Figure 5-131: DBM Extremity Market, France, 2005 - 2015 (US$) 149
  • Figure 5-132: Synthetic Extremity Market, France, 2005 - 2015 (€) 150
  • Figure 5-133: Synthetic Extremity Market, France, 2005 - 2015 (US$) 150
  • Figure 5-134: Allograft CMF Market, France, 2005 - 2015 (€) 152
  • Figure 5-135: Allograft CMF Market, France, 2005 - 2015 (US$) 152
  • Figure 5-136: DBM CMF Market, France, 2005 - 2015 (€) 153
  • Figure 5-137: DBM CMF Market, France, 2005 - 2015 (US$) 153
  • Figure 5-138: Synthetic CMF Market, France, 2005 - 2015 (€) 154
  • Figure 5-139: Synthetic CMF Market, France, 2005 - 2015 (US$) 154
  • Figure 5-140: Market Drivers and Limiters, France, Bone Graft Substitute Market, 2005 - 2015 155
  • Figure 5-141: Total Autograft Procedures, U.K., 2005 - 2015 156
  • Figure 5-142 Spine Fusion Procedures, U.K., 2005 - 2015 157
  • Figure 5-143: Total Bone Graft Substitute Market, U.K., 2005 - 2015 (€) 159
  • Figure 5-144: Total Bone Graft Substitute Market, U.K., 2005 - 2015 (US$) 159
  • Figure 5-145 Total Procedures by Indication, U.K., 2005 - 2015 160
  • Figure 5-146 Total Utilized Market Value by Indication, U.K., 2005 - 2015 (€) 161
  • Figure 5-147 Total Utilized Market Value by Indication, U.K., 2005 - 2015 (US$) 161
  • Figure 5-148: Utilized Bone Graft Substitute Market, U.K., 2005 - 2015 (€) 162
  • Figure 5-149: Utilized Bone Graft Substitute Market, U.K., 2005 - 2015 (US$) 162
  • Figure 5-150: Total Allograft Market, U.K., 2005 - 2015 (€) 164
  • Figure 5-151: Total Allograft Market, U.K., 2005 - 2015 (US$) 164
  • Figure 5-152: Total DBM Market, U.K., 2005 - 2015 (€) 165
  • Figure 5-153: Total DBM Market, U.K., 2005 - 2015 (US$) 165
  • Figure 5-154: Total Synthetic Market, U.K., 2005 - 2015 (€) 166
  • Figure 5-155: Total Synthetic Market, U.K., 2005 - 2015 (US$) 166
  • Figure 5-156: Allograft Spine Market, U.K., 2005 - 2015 (€) 168
  • Figure 5-157: Allograft Spine Market, U.K., 2005 - 2015 (US$) 168
  • Figure 5-158: DBM Spine Market, U.K., 2005 - 2015 (€) 169
  • Figure 5-159: DBM Spine Market, U.K., 2005 - 2015 (US$) 169
  • Figure 5-160: Synthetic Spine Market, U.K., 2005 - 2015 (€) 170
  • Figure 5-161: Synthetic Spine Market, U.K., 2005 - 2015 (US$) 170
  • Figure 5-162: Allograft Cervical Spine Market, U.K., 2005 - 2015 (€) 172
  • Figure 5-163: Allograft Cervical Spine Market, U.K., 2005 - 2015 (US$) 172
  • Figure 5-164: DBM Cervical Spine Market, U.K., 2005 - 2015 (€) 173
  • Figure 5-165: DBM Cervical Spine Market, U.K., 2005 - 2015 (US$) 173
  • Figure 5-166: Synthetic Cervical Spine Market, U.K., 2005 - 2015 (€) 174
  • Figure 5-167: Synthetic Cervical Spine Market, U.K., 2005 - 2015 (US$) 174
  • Figure 5-168: Allograft Thoracolumbar Spine Market, U.K., 2005 - 2015 (€) 176
  • Figure 5-169: Allograft Thoracolumbar Spine Market, U.K., 2005 - 2015 (US$) 176
  • Figure 5-170: DBM Thoracolumbar Spine Market, U.K., 2005 - 2015 (€) 177
  • Figure 5-171: DBM Thoracolumbar Spine Market, U.K., 2005 - 2015 (US$) 177
  • Figure 5-172: Synthetic Thoracolumbar Spine Market, U.K., 2005 - 2015 (€) 178
  • Figure 5-173: Synthetic Thoracolumbar Spine Market, U.K., 2005 - 2015 (US$)178
  • Figure 5-174: Allograft Extremity Market, U.K., 2005 - 2015 (€) 180
  • Figure 5-175: Allograft Extremity Market, U.K., 2005 - 2015 (US$) 180
  • Figure 5-176: DBM Extremity Market, U.K., 2005 - 2015 (€) 181
  • Figure 5-177: DBM Extremity Market, U.K., 2005 - 2015 (US$) 181
  • Figure 5-178: Synthetic Extremity Market, U.K., 2005 - 2015 (€) 182
  • Figure 5-179: Synthetic Extremity Market, U.K., 2005 - 2015 (US$) 182
  • Figure 5-180: Allograft CMF Market, U.K., 2005 - 2015 (€) 184
  • Figure 5-181: Allograft CMF Market, U.K., 2005 - 2015 (US$) 184
  • Figure 5-182: DBM CMF Market, U.K., 2005 - 2015 (€) 185
  • Figure 5-183: DBM CMF Market, U.K., 2005 - 2015 (US$) 185
  • Figure 5-184: Synthetic CMF Market, U.K., 2005 - 2015 (€) 186
  • Figure 5-185: Synthetic CMF Market, U.K., 2005 - 2015 (US$) 186
  • Figure 5-186: Market Drivers and Limiters, U.K., Bone Graft Substitute Market, 2005 - 2015 187
  • Figure 5-187: Total Autograft Procedures, Spain, 2005 - 2015 188
  • Figure 5-188 Spine Fusion Procedures, Spain, 2005 - 2015 189
  • Figure 5-189: Total Bone Graft Substitute Market, Spain, 2005 - 2015 (€) 191
  • Figure 5-190: Total Bone Graft Substitute Market, Spain, 2005 - 2015 (US$) 191
  • Figure 5-191 Total Procedures by Indication, Spain, 2005 - 2015 192
  • Figure 5-192 Total Utilized Market Value by Indication, Spain, 2005 - 2015 (€)193
  • Figure 5-193 Total Utilized Market Value by Indication, Spain, 2005 - 2015 (US$) 193
  • Figure 5-194: Utilized Bone Graft Substitute Market, Spain, 2005 - 2015 (€) 194
  • Figure 5-195: Utilized Bone Graft Substitute Market, Spain, 2005 - 2015 (US$) 194
  • Figure 5-196: Total Allograft Market, Spain, 2005 - 2015 (€) 196
  • Figure 5-197: Total Allograft Market, Spain, 2005 - 2015 (US$) 196
  • Figure 5-198: Total DBM Market, Spain, 2005 - 2015 (€) 197
  • Figure 5-199: Total DBM Market, Spain, 2005 - 2015 (US$) 197
  • Figure 5-200: Total Synthetic Market, Spain, 2005 - 2015 (€) 198
  • Figure 5-201: Total Synthetic Market, Spain, 2005 - 2015 (US$) 198
  • Figure 5-202: Allograft Spine Market, Spain, 2005 - 2015 (€) 200
  • Figure 5-203: Allograft Spine Market, Spain, 2005 - 2015 (US$) 200
  • Figure 5-204: DBM Spine Market, Spain, 2005 - 2015 (€) 201
  • Figure 5-205: DBM Spine Market, Spain, 2005 - 2015 (US$) 201
  • Figure 5-206: Synthetic Spine Market, Spain, 2005 - 2015 (€) 202
  • Figure 5-207: Synthetic Spine Market, Spain, 2005 - 2015 (US$) 202
  • Figure 5-208: Allograft Cervical Spine Market, Spain, 2005 - 2015 (€) 204
  • Figure 5-209: Allograft Cervical Spine Market, Spain, 2005 - 2015 (US$) 204
  • Figure 5-210: DBM Cervical Spine Market, Spain, 2005 - 2015 (€) 205
  • Figure 5-211: DBM Cervical Spine Market, Spain, 2005 - 2015 (US$) 205
  • Figure 5-212: Synthetic Cervical Spine Market, Spain, 2005 - 2015 (€) 206
  • Figure 5-213: Synthetic Cervical Spine Market, Spain, 2005 - 2015 (US$) 206
  • Figure 5-214: Allograft Thoracolumbar Spine Market, Spain, 2005 - 2015 (€) 208
  • Figure 5-215: Allograft Thoracolumbar Spine Market, Spain, 2005 - 2015 (US$)208
  • Figure 5-216: DBM Thoracolumbar Spine Market, Spain, 2005 - 2015 (€) 209
  • Figure 5-217: DBM Thoracolumbar Spine Market, Spain, 2005 - 2015 (US$) 209
  • Figure 5-218: Synthetic Thoracolumbar Spine Market, Spain, 2005 - 2015 (€) 210
  • Figure 5-219: Synthetic Thoracolumbar Spine Market, Spain, 2005 - 2015 (US$)210
  • Figure 5-220: Allograft Extremity Market, Spain, 2005 - 2015 (€) 212
  • Figure 5-221: Allograft Extremity Market, Spain, 2005 - 2015 (US$) 212
  • Figure 5-222: DBM Extremity Market, Spain, 2005 - 2015 (€) 213
  • Figure 5-223: DBM Extremity Market, Spain, 2005 - 2015 (US$) 213
  • Figure 5-224: Synthetic Extremity Market, Spain, 2005 - 2015 (€) 214
  • Figure 5-225: Synthetic Extremity Market, Spain, 2005 - 2015 (US$) 214
  • Figure 5-226: Allograft CMF Market, Spain, 2005 - 2015 (€) 216
  • Figure 5-227: Allograft CMF Market, Spain, 2005 - 2015 (US$) 216
  • Figure 5-228: DBM CMF Market, Spain, 2005 - 2015 (€) 217
  • Figure 5-229: DBM CMF Market, Spain, 2005 - 2015 (US$) 217
  • Figure 5-230: Synthetic CMF Market, Spain, 2005 - 2015 (€) 218
  • Figure 5-231: Synthetic CMF Market, Spain, 2005 - 2015 (US$) 218
  • Figure 5-232: Market Drivers and Limiters, Spain, Bone Graft Substitute Market, 2005 - 2015 219
  • Figure 5-233: Total Autograft Procedures, Italy, 2005 - 2015 220
  • Figure 5-234 Spine Fusion Procedures, Italy, 2005 - 2015 221
  • Figure 5-235: Total Bone Graft Substitute Market, Italy, 2005 - 2015 (€) 223
  • Figure 5-236: Total Bone Graft Substitute Market, Italy, 2005 - 2015 (US$) 223
  • Figure 5-237 Total Procedures by Indication, Italy, 2005 - 2015 224
  • Figure 5-238 Total Utilized Market Value by Indication, Italy, 2005 - 2015 (€) 225
  • Figure 5-239 Total Utilized Market Value by Indication, Italy, 2005 - 2015 (US$) 225
  • Figure 5-240: Utilized Bone Graft Substitute Market, Italy, 2005 - 2015 (€) 226
  • Figure 5-241: Utilized Bone Graft Substitute Market, Italy, 2005 - 2015 (US$) 226
  • Figure 5-242: Total Allograft Market, Italy, 2005 - 2015 (€) 228
  • Figure 5-243: Total Allograft Market, Italy, 2005 - 2015 (US$) 228
  • Figure 5-244: Total DBM Market, Italy, 2005 - 2015 (€) 229
  • Figure 5-245: Total DBM Market, Italy, 2005 - 2015 (US$) 229
  • Figure 5-246: Total Synthetic Market, Italy, 2005 - 2015 (€) 230
  • Figure 5-247: Total Synthetic Market, Italy, 2005 - 2015 (US$) 230
  • Figure 5-248: Allograft Spine Market, Italy, 2005 - 2015 (€) 232
  • Figure 5-249: Allograft Spine Market, Italy, 2005 - 2015 (US$) 232
  • Figure 5-250: DBM Spine Market, Italy, 2005 - 2015 (€) 233
  • Figure 5-251: DBM Spine Market, Italy, 2005 - 2015 (US$) 233
  • Figure 5-252: Synthetic Spine Market, Italy, 2005 - 2015 (€) 234
  • Figure 5-253: Synthetic Spine Market, Italy, 2005 - 2015 (US$) 234
  • Figure 5-254: Allograft Cervical Spine Market, Italy, 2005 - 2015 (€) 236
  • Figure 5-255: Allograft Cervical Spine Market, Italy, 2005 - 2015 (US$) . 236
  • Figure 5-256: DBM Cervical Spine Market, Italy, 2005 - 2015 (€) 237
  • Figure 5-257: DBM Cervical Spine Market, Italy, 2005 - 2015 (US$) 237
  • Figure 5-258: Synthetic Cervical Spine Market, Italy, 2005 - 2015 (€) 238
  • Figure 5-259: Synthetic Cervical Spine Market, Italy, 2005 - 2015 (US$) 238
  • Figure 5-260: Allograft Thoracolumbar Spine Market, Italy, 2005 - 2015 (€) 240
  • Figure 5-261: Allograft Thoracolumbar Spine Market, Italy, 2005 - 2015 (US$) 240
  • Figure 5-262: DBM Thoracolumbar Spine Market, Italy, 2005 - 2015 (€) . 241
  • Figure 5-263: DBM Thoracolumbar Spine Market, Italy, 2005 - 2015 (US$) 241
  • Figure 5-264: Synthetic Thoracolumbar Spine Market, Italy, 2005 - 2015 (€) 242
  • Figure 5-265: Synthetic Thoracolumbar Spine Market, Italy, 2005 - 2015 (US$)242
  • Figure 5-266: Allograft Extremity Market, Italy, 2005 - 2015 (€) 244
  • Figure 5-267: Allograft Extremity Market, Italy, 2005 - 2015 (US$) 244
  • Figure 5-268: DBM Extremity Market, Italy, 2005 - 2015 (€) 245
  • Figure 5-269: DBM Extremity Market, Italy, 2005 - 2015 (US$) 245
  • Figure 5-270: Synthetic Extremity Market, Italy, 2005 - 2015 (€) 246
  • Figure 5-271: Synthetic Extremity Market, Italy, 2005 - 2015 (US$) 246
  • Figure 5-272: Allograft CMF Market, Italy, 2005 - 2015 (€) 248
  • Figure 5-273: Allograft CMF Market, Italy, 2005 - 2015 (US$) 248
  • Figure 5-274: DBM CMF Market, Italy, 2005 - 2015 (€) 249
  • Figure 5-275: DBM CMF Market, Italy, 2005 - 2015 (US$) 249
  • Figure 5-276: Synthetic CMF Market, Italy, 2005 - 2015 (€) 250
  • Figure 5-277: Synthetic CMF Market, Italy, 2005 - 2015 (US$) 250
  • Figure 5-278: Market Drivers and Limiters, Italy, Bone Graft Substitute Market, 2005 - 2015 251
  • Figure 5-279: Total Autograft Procedures, Benelux, 2005 - 2015 252
  • Figure 5-280 Spine Fusion Procedures, Benelux, 2005 - 2015 253
  • Figure 5-281: Total Bone Graft Substitute Market, Benelux, 2005 - 2015 (€) 255
  • Figure 5-282: Total Bone Graft Substitute Market, Benelux, 2005 - 2015 (US$) 255
  • Figure 5-283 Total Procedures by Indication, Benelux, 2005 - 2015 256
  • Figure 5-284 Total Utilized Market Value by Indication, Benelux, 2005 - 2015 (€) 257
  • Figure 5-285 Total Utilized Market Value by Indication, Benelux, 2005 - 2015 (US$) 257
  • Figure 5-286: Utilized Bone Graft Substitute Market, Benelux, 2005 - 2015 (€) 258
  • Figure 5-287: Utilized Bone Graft Substitute Market, Benelux, 2005 - 2015 (US$) 258
  • Figure 5-288: Total Allograft Market, Benelux, 2005 - 2015 (€) 260
  • Figure 5-289: Total Allograft Market, Benelux, 2005 - 2015 (US$) 260
  • Figure 5-290: Total DBM Market, Benelux, 2005 - 2015 (€) 261
  • Figure 5-291: Total DBM Market, Benelux, 2005 - 2015 (US$) 261
  • Figure 5-292: Total Synthetic Market, Benelux, 2005 - 2015 (€) 262
  • Figure 5-293: Total Synthetic Market, Benelux, 2005 - 2015 (US$) 262
  • Figure 5-294: Allograft Spine Market, Benelux, 2005 - 2015 (€) 264
  • Figure 5-295: Allograft Spine Market, Benelux, 2005 - 2015 (US$) 264
  • Figure 5-296: DBM Spine Market, Benelux, 2005 - 2015 (€) 265
  • Figure 5-297: DBM Spine Market, Benelux, 2005 - 2015 (US$) 265
  • Figure 5-298: Synthetic Spine Market, Benelux, 2005 - 2015 (€) 266
  • Figure 5-299: Synthetic Spine Market, Benelux, 2005 - 2015 (US$) 266
  • Figure 5-300: Allograft Cervical Spine Market, Benelux, 2005 - 2015 (€) 268
  • Figure 5-301: Allograft Cervical Spine Market, Benelux, 2005 - 2015 (US$) 268
  • Figure 5-302: DBM Cervical Spine Market, Benelux, 2005 - 2015 (€) 269
  • Figure 5-303: DBM Cervical Spine Market, Benelux, 2005 - 2015 (US$) 269
  • Figure 5-304: Synthetic Cervical Spine Market, Benelux, 2005 - 2015 (€) 270
  • Figure 5-305: Synthetic Cervical Spine Market, Benelux, 2005 - 2015 (US$) 270
  • Figure 5-306: Allograft Thoracolumbar Spine Market, Benelux, 2005 - 2015 (€)272
  • Figure 5-307: Allograft Thoracolumbar Spine Market, Benelux, 2005 - 2015 (US$) 272
  • Figure 5-308: DBM Thoracolumbar Spine Market, Benelux, 2005 - 2015 (€) 273
  • Figure 5-309: DBM Thoracolumbar Spine Market, Benelux, 2005 - 2015 (US$) 273
  • Figure 5-310: Synthetic Thoracolumbar Spine Market, Benelux, 2005 - 2015 (€)274
  • Figure 5-311: Synthetic Thoracolumbar Spine Market, Benelux, 2005 - 2015 (US$) 274
  • Figure 5-312: Allograft Extremity Market, Benelux, 2005 - 2015 (€) 276
  • Figure 5-313: Allograft Extremity Market, Benelux, 2005 - 2015 (US$) 276
  • Figure 5-314: DBM Extremity Market, Benelux, 2005 - 2015 (€) 277
  • Figure 5-315: DBM Extremity Market, Benelux, 2005 - 2015 (US$) 277
  • Figure 5-316: Synthetic Extremity Market, Benelux, 2005 - 2015 (€) 278
  • Figure 5-317: Synthetic Extremity Market, Benelux, 2005 - 2015 (US$) 278
  • Figure 5-318: Allograft CMF Market, Benelux, 2005 - 2015 (€) 280
  • Figure 5-319: Allograft CMF Market, Benelux, 2005 - 2015 (US$) 280
  • Figure 5-320: DBM CMF Market, Benelux, 2005 - 2015 (€) 281
  • Figure 5-321: DBM CMF Market, Benelux, 2005 - 2015 (US$) 281
  • Figure 5-322: Synthetic CMF Market, Benelux, 2005 - 2015 (€) 282
  • Figure 5-323: Synthetic CMF Market, Benelux, 2005 - 2015 (US$) 282
  • Figure 5-324: Market Drivers and Limiters, Benelux, Bone Graft Substitute Market, 2005 - 2015 283
  • Figure 5-325: Total Autograft Procedures, Scandinavia, 2005 - 2015 284
  • Figure 5-326 Spine Fusion Procedures, Scandinavia, 2005 - 2015 285
  • Figure 5-327: Total Bone Graft Substitute Market, Scandinavia, 2005 - 2015 (€)287
  • Figure 5-328: Total Bone Graft Substitute Market, Scandinavia, 2005 - 2015 (US$) 287
  • Figure 5-329 Total Procedures by Indication, Scandinavia, 2005 - 2015 288
  • Figure 5-330 Total Utilized Market Value by Indication, Scandinavia, 2005 - 2015 (€) 289
  • Figure 5-331 Total Utilized Market Value by Indication, Scandinavia, 2005 - 2015 (US$) 289
  • Figure 5-332: Utilized Bone Graft Substitute Market, Scandinavia, 2005 - 2015 (€) 290
  • Figure 5-333: Utilized Bone Graft Substitute Market, Scandinavia, 2005 - 2015 (US$) 290
  • Figure 5-334: Total Allograft Market, Scandinavia, 2005 - 2015 (€) 292
  • Figure 5-335: Total Allograft Market, Scandinavia, 2005 - 2015 (US$) 292
  • Figure 5-336: Total DBM Market, Scandinavia, 2005 - 2015 (€) 293
  • Figure 5-337: Total DBM Market, Scandinavia, 2005 - 2015 (US$) 293
  • Figure 5-338: Total Synthetic Market, Scandinavia, 2005 - 2015 (€) 294
  • Figure 5-339: Total Synthetic Market, Scandinavia, 2005 - 2015 (US$) 294
  • Figure 5-340: Allograft Spine Market, Scandinavia, 2005 - 2015 (€) 296
  • Figure 5-341: Allograft Spine Market, Scandinavia, 2005 - 2015 (US$) 296
  • Figure 5-342: DBM Spine Market, Scandinavia, 2005 - 2015 (€) 297
  • Figure 5-343: DBM Spine Market, Scandinavia, 2005 - 2015 (US$) 297
  • Figure 5-344: Synthetic Spine Market, Scandinavia, 2005 - 2015 (€) 298
  • Figure 5-345: Synthetic Spine Market, Scandinavia, 2005 - 2015 (US$) 298
  • Figure 5-346: Allograft Cervical Spine Market, Scandinavia, 2005 - 2015 (€) 300
  • Figure 5-347: Allograft Cervical Spine Market, Scandinavia, 2005 - 2015 (US$)300
  • Figure 5-348: DBM Cervical Spine Market, Scandinavia, 2005 - 2015 (€) 301
  • Figure 5-349: DBM Cervical Spine Market, Scandinavia, 2005 - 2015 (US$) 301
  • Figure 5-350: Synthetic Cervical Spine Market, Scandinavia, 2005 - 2015 (€) 302
  • Figure 5-351: Synthetic Cervical Spine Market, Scandinavia, 2005 - 2015 (US$)302
  • Figure 5-352: Allograft Thoracolumbar Spine Market, Scandinavia, 2005 - 2015 (€) 304
  • Figure 5-353: Allograft Thoracolumbar Spine Market, Scandinavia, 2005 - 2015 (US$) 304
  • Figure 5-354: DBM Thoracolumbar Spine Market, Scandinavia, 2005 - 2015 (€)305
  • Figure 5-355: DBM Thoracolumbar Spine Market, Scandinavia, 2005 - 2015 (US$) 305
  • Figure 5-356: Synthetic Thoracolumbar Spine Market, Scandinavia, 2005 - 2015 (€) 306
  • Figure 5-357: Synthetic Thoracolumbar Spine Market, Scandinavia, 2005 - 2015 (US$) 306
  • Figure 5-358: Allograft Extremity Market, Scandinavia, 2005 - 2015 (€) 308
  • Figure 5-359: Allograft Extremity Market, Scandinavia, 2005 - 2015 (US$) 308
  • Figure 5-360: DBM Extremity Market, Scandinavia, 2005 - 2015 (€) 309
  • Figure 5-361: DBM Extremity Market, Scandinavia, 2005 - 2015 (US$) 309
  • Figure 5-362: Synthetic Extremity Market, Scandinavia, 2005 - 2015 (€) 310
  • Figure 5-363: Synthetic Extremity Market, Scandinavia, 2005 - 2015 (US$) 310
  • Figure 5-364: Allograft CMF Market, Scandinavia, 2005 - 2015 (€) 312
  • Figure 5-365: Allograft CMF Market, Scandinavia, 2005 - 2015 (US$) 312
  • Figure 5-366: DBM CMF Market, Scandinavia, 2005 - 2015 (€) 313
  • Figure 5-367: DBM CMF Market, Scandinavia, 2005 - 2015 (US$) 313
  • Figure 5-368: Synthetic CMF Market, Scandinavia, 2005 - 2015 (€) 314
  • Figure 5-369: Synthetic CMF Market, Scandinavia, 2005 - 2015 (US$) 314
  • Figure 5-370: Market Drivers and Limiters, Scandinavia, Bone Graft Substitute Market, 2005 - 2015 316
  • Figure 5-371: Total Autograft Procedures, Switzerland, 2005 - 2015 317
  • Figure 5-372 Spine Fusion Procedures, Switzerland, 2005 - 2015 318
  • Figure 5-373: Total Bone Graft Substitute Market, Switzerland, 2005 - 2015 (€)320
  • Figure 5-374: Total Bone Graft Substitute Market, Switzerland, 2005 - 2015 (US$) 320
  • Figure 5-375 Total Procedures by Indication, Switzerland, 2005 - 2015 321
  • Figure 5-376 Total Utilized Market Value by Indication, Switzerland, 2005 - 2015 (€) 322
  • Figure 5-377 Total Utilized Market Value by Indication, Switzerland, 2005 - 2015 (US$) 322
  • Figure 5-378: Utilized Bone Graft Substitute Market, Switzerland, 2005 - 2015 (€) 323
  • Figure 5-379: Utilized Bone Graft Substitute Market, Switzerland, 2005 - 2015 (US$) 323
  • Figure 5-380: Total Allograft Market, Switzerland, 2005 - 2015 (€) 325
  • Figure 5-381: Total Allograft Market, Switzerland, 2005 - 2015 (US$) 325
  • Figure 5-382: Total DBM Market, Switzerland, 2005 - 2015 (€) 326
  • Figure 5-383: Total DBM Market, Switzerland, 2005 - 2015 (US$) 326
  • Figure 5-384: Total Synthetic Market, Switzerland, 2005 - 2015 (€) 327
  • Figure 5-385: Total Synthetic Market, Switzerland, 2005 - 2015 (US$) 327
  • Figure 5-386: Allograft Spine Market, Switzerland, 2005 - 2015 (€) 329
  • Figure 5-387: Allograft Spine Market, Switzerland, 2005 - 2015 (US$) 329
  • Figure 5-388: DBM Spine Market, Switzerland, 2005 - 2015 (€) 330
  • Figure 5-389: DBM Spine Market, Switzerland, 2005 - 2015 (US$) 330
  • Figure 5-390: Synthetic Spine Market, Switzerland, 2005 - 2015 (€) 331
  • Figure 5-391: Synthetic Spine Market, Switzerland, 2005 - 2015 (US$) 331
  • Figure 5-392: Allograft Cervical Spine Market, Switzerland, 2005 - 2015 (€) 333
  • Figure 5-393: Allograft Cervical Spine Market, Switzerland, 2005 - 2015 (US$)333
  • Figure 5-394: DBM Cervical Spine Market, Switzerland, 2005 - 2015 (€) 334
  • Figure 5-395: DBM Cervical Spine Market, Switzerland, 2005 - 2015 (US$) 334
  • Figure 5-396: Synthetic Cervical Spine Market, Switzerland, 2005 - 2015 (€) 335
  • Figure 5-397: Synthetic Cervical Spine Market, Switzerland, 2005 - 2015 (US$)335
  • Figure 5-398: Allograft Thoracolumbar Spine Market, Switzerland, 2005 - 2015 (€) 337
  • Figure 5-399: Allograft Thoracolumbar Spine Market, Switzerland, 2005 - 2015 (US$) 337
  • Figure 5-400: DBM Thoracolumbar Spine Market, Switzerland, 2005 - 2015 (€)338
  • Figure 5-401: DBM Thoracolumbar Spine Market, Switzerland, 2005 - 2015 (US$) 338
  • Figure 5-402: Synthetic Thoracolumbar Spine Market, Switzerland, 2005 - 2015 (€) 339
  • Figure 5-403: Synthetic Thoracolumbar Spine Market, Switzerland, 2005 - 2015 (US$) 339
  • Figure 5-404: Allograft Extremity Market, Switzerland, 2005 - 2015 (€) 341
  • Figure 5-405: Allograft Extremity Market, Switzerland, 2005 - 2015 (US$) 341
  • Figure 5-406: DBM Extremity Market, Switzerland, 2005 - 2015 (€) 342
  • Figure 5-407: DBM Extremity Market, Switzerland, 2005 - 2015 (US$) 342
  • Figure 5-408: Synthetic Extremity Market, Switzerland, 2005 - 2015 (€) 343
  • Figure 5-409: Synthetic Extremity Market, Switzerland, 2005 - 2015 (US$) 343
  • Figure 5-410: Allograft CMF Market, Switzerland, 2005 - 2015 (€) 345
  • Figure 5-411: Allograft CMF Market, Switzerland, 2005 - 2015 (US$) 345
  • Figure 5-412: DBM CMF Market, Switzerland, 2005 - 2015 (€) 346
  • Figure 5-413: DBM CMF Market, Switzerland, 2005 - 2015 (US$) 346
  • Figure 5-414: Synthetic CMF Market, Switzerland, 2005 - 2015 (€) 347
  • Figure 5-415: Synthetic CMF Market, Switzerland, 2005 - 2015 (US$) 347
  • Figure 5-416: Market Drivers and Limiters, Switzerland, Bone Graft Substitute Market, 2005 - 2015 348
  • Figure 5-417: Total Autograft Procedures, Austria, 2005 - 2015 349
  • Figure 5-418 Spine Fusion Procedures, Austria, 2005 - 2015 350
  • Figure 5-419: Total Bone Graft Substitute Market, Austria, 2005 - 2015 (€) 352
  • Figure 5-420: Total Bone Graft Substitute Market, Austria, 2005 - 2015 (US$) . 352
  • Figure 5-421 Total Procedures by Indication, Austria, 2005 - 2015 353
  • Figure 5-422 Total Utilized Market Value by Indication, Austria, 2005 - 2015 (€)354
  • Figure 5-423 Total Utilized Market Value by Indication, Austria, 2005 - 2015 (US$) 354
  • Figure 5-424: Utilized Bone Graft Substitute Market, Austria, 2005 - 2015 (€) . 355
  • Figure 5-425: Utilized Bone Graft Substitute Market, Austria, 2005 - 2015 (US$)355
  • Figure 5-426: Total Allograft Market, Austria, 2005 - 2015 (€) 357
  • Figure 5-427: Total Allograft Market, Austria, 2005 - 2015 (US$) 357
  • Figure 5-428: Total DBM Market, Austria, 2005 - 2015 (€) 358
  • Figure 5-429: Total DBM Market, Austria, 2005 - 2015 (US$) 358
  • Figure 5-430: Total Synthetic Market, Austria, 2005 - 2015 (€) 359
  • Figure 5-431: Total Synthetic Market, Austria, 2005 - 2015 (US$) 359
  • Figure 5-432: Allograft Spine Market, Austria, 2005 - 2015 (€) 361
  • Figure 5-433: Allograft Spine Market, Austria, 2005 - 2015 (US$) 361
  • Figure 5-434: DBM Spine Market, Austria, 2005 - 2015 (€) 362
  • Figure 5-435: DBM Spine Market, Austria, 2005 - 2015 (US$) 362
  • Figure 5-436: Synthetic Spine Market, Austria, 2005 - 2015 (€) 363
  • Figure 5-437: Synthetic Spine Market, Austria, 2005 - 2015 (US$) 363
  • Figure 5-438: Allograft Cervical Spine Market, Austria, 2005 - 2015 (€) 365
  • Figure 5-439: Allograft Cervical Spine Market, Austria, 2005 - 2015 (US$) 365
  • Figure 5-440: DBM Cervical Spine Market, Austria, 2005 - 2015 (€) 366
  • Figure 5-441: DBM Cervical Spine Market, Austria, 2005 - 2015 (US$) 366
  • Figure 5-442: Synthetic Cervical Spine Market, Austria, 2005 - 2015 (€) 367
  • Figure 5-443: Synthetic Cervical Spine Market, Austria, 2005 - 2015 (US$) 367
  • Figure 5-444: Allograft Thoracolumbar Spine Market, Austria, 2005 - 2015 (€) 369
  • Figure 5-445: Allograft Thoracolumbar Spine Market, Austria, 2005 - 2015 (US$) 369
  • Figure 5-446: DBM Thoracolumbar Spine Market, Austria, 2005 - 2015 (€) 370
  • Figure 5-447: DBM Thoracolumbar Spine Market, Austria, 2005 - 2015 (US$) 370
  • Figure 5-448: Synthetic Thoracolumbar Spine Market, Austria, 2005 - 2015 (€) 371
  • Figure 5-449: Synthetic Thoracolumbar Spine Market, Austria, 2005 - 2015 (US$) 371
  • Figure 5-450: Allograft Extremity Market, Austria, 2005 - 2015 (€) 373
  • Figure 5-451: Allograft Extremity Market, Austria, 2005 - 2015 (US$) 373
  • Figure 5-452: DBM Extremity Market, Austria, 2005 - 2015 (€) 374
  • Figure 5-453: DBM Extremity Market, Austria, 2005 - 2015 (US$) 374
  • Figure 5-454: Synthetic Extremity Market, Austria, 2005 - 2015 (€) 375
  • Figure 5-455: Synthetic Extremity Market, Austria, 2005 - 2015 (US$) 375
  • Figure 5-456: Allograft CMF Market, Austria, 2005 - 2015 (€) 377
  • Figure 5-457: Allograft CMF Market, Austria, 2005 - 2015 (US$) 377
  • Figure 5-458: DBM CMF Market, Austria, 2005 - 2015 (€) 378
  • Figure 5-459: DBM CMF Market, Austria, 2005 - 2015 (US$) 378
  • Figure 5-460: Synthetic CMF Market, Austria, 2005 - 2015 (€) 379
  • Figure 5-461: Synthetic CMF Market, Austria, 2005 - 2015 (US$) 379
  • Figure 5-462: Market Drivers and Limiters, Austria, Bone Graft Substitute Market, 2005 - 2015 380
  • Figure 5-463: Total Autograft Procedures, Portugal, 2005 - 2015 381
  • Figure 5-464 Spine Fusion Procedures, Portugal, 2005 - 2015 382
  • Figure 5-465: Total Bone Graft Substitute Market, Portugal, 2005 - 2015 (€) 384
  • Figure 5-466: Total Bone Graft Substitute Market, Portugal, 2005 - 2015 (US$) 384
  • Figure 5-467 Total Procedures by Indication, Portugal, 2005 - 2015 385
  • Figure 5-468 Total Utilized Market Value by Indication, Portugal, 2005 - 2015 (€) 386
  • Figure 5-469 Total Utilized Market Value by Indication, Portugal, 2005 - 2015 (US$) 386
  • Figure 5-470: Utilized Bone Graft Substitute Market, Portugal, 2005 - 2015 (€) 387
  • Figure 5-471: Utilized Bone Graft Substitute Market, Portugal, 2005 - 2015 (US$) 387
  • Figure 5-472: Total Allograft Market, Portugal, 2005 - 2015 (€) 389
  • Figure 5-473: Total Allograft Market, Portugal, 2005 - 2015 (US$) 389
  • Figure 5-474: Total DBM Market, Portugal, 2005 - 2015 (€) 390
  • Figure 5-475: Total DBM Market, Portugal, 2005 - 2015 (US$) 390
  • Figure 5-476: Total Synthetic Market, Portugal, 2005 - 2015 (€) 391
  • Figure 5-477: Total Synthetic Market, Portugal, 2005 - 2015 (US$) 391
  • Figure 5-478: Allograft Spine Market, Portugal, 2005 - 2015 (€) 393
  • Figure 5-479: Allograft Spine Market, Portugal, 2005 - 2015 (US$) 393
  • Figure 5-480: DBM Spine Market, Portugal, 2005 - 2015 (€) 394
  • Figure 5-481: DBM Spine Market, Portugal, 2005 - 2015 (US$) 394
  • Figure 5-482: Synthetic Spine Market, Portugal, 2005 - 2015 (€) 395
  • Figure 5-483: Synthetic Spine Market, Portugal, 2005 - 2015 (US$) 395
  • Figure 5-484: Allograft Cervical Spine Market, Portugal, 2005 - 2015 (€) 397
  • Figure 5-485: Allograft Cervical Spine Market, Portugal, 2005 - 2015 (US$) 397
  • Figure 5-486: DBM Cervical Spine Market, Portugal, 2005 - 2015 (€) 398
  • Figure 5-487: DBM Cervical Spine Market, Portugal, 2005 - 2015 (US$) 398
  • Figure 5-488: Synthetic Cervical Spine Market, Portugal, 2005 - 2015 (€) 399
  • Figure 5-489: Synthetic Cervical Spine Market, Portugal, 2005 - 2015 (US$) 399
  • Figure 5-490: Allograft Thoracolumbar Spine Market, Portugal, 2005 - 2015 (€)401
  • Figure 5-491: Allograft Thoracolumbar Spine Market, Portugal, 2005 - 2015 (US$) 401
  • Figure 5-492: DBM Thoracolumbar Spine Market, Portugal, 2005 - 2015 (€) 402
  • Figure 5-493: DBM Thoracolumbar Spine Market, Portugal, 2005 - 2015 (US$) 402
  • Figure 5-494: Synthetic Thoracolumbar Spine Market, Portugal, 2005 - 2015 (€)403
  • Figure 5-495: Synthetic Thoracolumbar Spine Market, Portugal, 2005 - 2015 (US$) 403
  • Figure 5-496: Allograft Extremity Market, Portugal, 2005 - 2015 (€) 405
  • Figure 5-497: Allograft Extremity Market, Portugal, 2005 - 2015 (US$) 405
  • Figure 5-498: DBM Extremity Market, Portugal, 2005 - 2015 (€) 406
  • Figure 5-499: DBM Extremity Market, Portugal, 2005 - 2015 (US$) 406
  • Figure 5-500: Synthetic Extremity Market, Portugal, 2005 - 2015 (€) 407
  • Figure 5-501: Synthetic Extremity Market, Portugal, 2005 - 2015 (US$) 407
  • Figure 5-502: Allograft CMF Market, Portugal, 2005 - 2015 (€) 409
  • Figure 5-503: Allograft CMF Market, Portugal, 2005 - 2015 (US$) 409
  • Figure 5-504: DBM CMF Market, Portugal, 2005 - 2015 (€) 410
  • Figure 5-505: DBM CMF Market, Portugal, 2005 - 2015 (US$) 410
  • Figure 5-506: Synthetic CMF Market, Portugal, 2005 - 2015 (€) 411
  • Figure 5-507: Synthetic CMF Market, Portugal, 2005 - 2015 (US$) 411
  • Figure 5-508: Market Drivers and Limiters, Portugal, Bone Graft Substitute Market, 2005 - 2015 412
  • Figure 5-509: Total Autograft Procedures, Greece, 2005 - 2015 413
  • Figure 5-510 Spine Fusion Procedures, Greece, 2005 - 2015 414
  • Figure 5-511: Total Bone Graft Substitute Market, Greece, 2005 - 2015 (€) 416
  • Figure 5-512: Total Bone Graft Substitute Market, Greece, 2005 - 2015 (US$) 416
  • Figure 5-513 Total Procedures by Indication, Greece, 2005 - 2015 417
  • Figure 5-514 Total Utilized Market Value by Indication, Greece, 2005 - 2015 (€)418
  • Figure 5-515 Total Utilized Market Value by Indication, Greece, 2005 - 2015 (US$) 418
  • Figure 5-516: Utilized Bone Graft Substitute Market, Greece, 2005 - 2015 (€) 419
  • Figure 5-517: Utilized Bone Graft Substitute Market, Greece, 2005 - 2015 (US$)419
  • Figure 5-518: Total Allograft Market, Greece, 2005 - 2015 (€) 421
  • Figure 5-519: Total Allograft Market, Greece, 2005 - 2015 (US$) 421
  • Figure 5-520: Total DBM Market, Greece, 2005 - 2015 (€) 422
  • Figure 5-521: Total DBM Market, Greece, 2005 - 2015 (US$) 422
  • Figure 5-522: Total Synthetic Market, Greece, 2005 - 2015 (€) 423
  • Figure 5-523: Total Synthetic Market, Greece, 2005 - 2015 (US$) 423
  • Figure 5-524: Allograft Spine Market, Greece, 2005 - 2015 (€) 425
  • Figure 5-525: Allograft Spine Market, Greece, 2005 - 2015 (US$) 425
  • Figure 5-526: DBM Spine Market, Greece, 2005 - 2015 (€) 426
  • Figure 5-527: DBM Spine Market, Greece, 2005 - 2015 (US$) 426
  • Figure 5-528: Synthetic Spine Market, Greece, 2005 - 2015 (€) 427
  • Figure 5-529: Synthetic Spine Market, Greece, 2005 - 2015 (US$) 427
  • Figure 5-530: Allograft Cervical Spine Market, Greece, 2005 - 2015 (€) 429
  • Figure 5-531: Allograft Cervical Spine Market, Greece, 2005 - 2015 (US$) 429
  • Figure 5-532: DBM Cervical Spine Market, Greece, 2005 - 2015 (€) 430
  • Figure 5-533: DBM Cervical Spine Market, Greece, 2005 - 2015 (US$) 430
  • Figure 5-534: Synthetic Cervical Spine Market, Greece, 2005 - 2015 (€) 431
  • Figure 5-535: Synthetic Cervical Spine Market, Greece, 2005 - 2015 (US$) 431
  • Figure 5-536: Allograft Thoracolumbar Spine Market, Greece, 2005 - 2015 (€) 433
  • Figure 5-537: Allograft Thoracolumbar Spine Market, Greece, 2005 - 2015 (US$) 433
  • Figure 5-538: DBM Thoracolumbar Spine Market, Greece, 2005 - 2015 (€) 434
  • Figure 5-539: DBM Thoracolumbar Spine Market, Greece, 2005 - 2015 (US$) 434
  • Figure 5-540: Synthetic Thoracolumbar Spine Market, Greece, 2005 - 2015 (€) 435
  • Figure 5-541: Synthetic Thoracolumbar Spine Market, Greece, 2005 - 2015 (US$) 435
  • Figure 5-542: Allograft Extremity Market, Greece, 2005 - 2015 (€) 437
  • Figure 5-543: Allograft Extremity Market, Greece, 2005 - 2015 (US$) 437
  • Figure 5-544: DBM Extremity Market, Greece, 2005 - 2015 (€) 438
  • Figure 5-545: DBM Extremity Market, Greece, 2005 - 2015 (US$) 438
  • Figure 5-546: Synthetic Extremity Market, Greece, 2005 - 2015 (€) 439
  • Figure 5-547: Synthetic Extremity Market, Greece, 2005 - 2015 (US$) 439
  • Figure 5-548: Allograft CMF Market, Greece, 2005 - 2015 (€) 441
  • Figure 5-549: Allograft CMF Market, Greece, 2005 - 2015 (US$) 441
  • Figure 5-550: DBM CMF Market, Greece, 2005 - 2015 (€) 442
  • Figure 5-551: DBM CMF Market, Greece, 2005 - 2015 (US$) 442
  • Figure 5-552: Synthetic CMF Market, Greece, 2005 - 2015 (€) 443
  • Figure 5-553: Synthetic CMF Market, Greece, 2005 - 2015 (US$) 443
  • Figure 5-554: Market Drivers and Limiters, Greece, Bone Graft Substitute Market, 2005 - 2015 444

BMP GROWTH FACTOR MARKET 445

  • Figure 6-1: Orthopedic Growth Factor Market, Europe, 2005 - 2015 (€) 448
  • Figure 6-2: Orthopedic Growth Factor Market, Europe, 2005 - 2015 ($US) 448
  • Figure 6-3: Drivers and Limiters, Orthopedic Growth Factor Market, Europe, 2005 - 2015 450
  • Figure 6-4: Leading Competitors, Orthopedic Growth Factor Market, Europe, 2008 451

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 454

  • Figure 7-1: Total Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 (€) 457
  • Figure 7-2: Total Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 ($US) 457
  • Figure 7-3: Single-Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 (€) 459
  • Figure 7-4: Single-Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 ($US) 459
  • Figure 7-5: Three-Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 (€) 461
  • Figure 7-6: Three-Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 ($US) 461
  • Figure 7-7: Five-Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 (€) 463
  • Figure 7-8: Five-Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 ($US) 463
  • Figure 7-9: Hyaluronic Acid Viscosupplementation Injections per Country, Europe, 2008 464
  • Figure 7-10: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, Europe, 2005 - 2015 466
  • Figure 7-11: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Europe, 2008 468

AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET 470

  • Figure 8-1: ACI Market, Europe, 2005 - 2015 (€) 473
  • Figure 8-2: ACI Market, Europe, 2005 - 2015 ($US) 473
  • Figure 8-3: Drivers and Limiters, ACI Market, Europe, 2005 - 2015 474
  • Figure 8-4: Leading Competitors, Autologous Chondrocyte Implantation Market, Europe, 2008 477
  • Figure 8-5: Leading Competitors, Autologous Chondrocyte Implantation Market, Europe, 2008 477

PLATELET AND BONE MARROW CONCENTRATION MARKET 478

  • Figure 9-1: Total Cell Concentration Market, Europe, 2005 - 2015 (€) 481
  • Figure 9-2: Total Cell Concentration Market, Europe, 2005 - 2015 (€) 482
  • Figure 9-3: Total Cell Concentration Market, Europe, 2005 - 2015 ($US) 482
  • Figure 9-4: Platelet Concentration Market, Europe, 2005 - 2015 (€) 484
  • Figure 9-5: Platelet Concentration Market, Europe, 2005 - 2015 ($US) 484
  • Figure 9-6: Bone Marrow Concentration Market, Europe, 2005 - 2015 (€) 486
  • Figure 9-7: Bone Marrow Concentration Market, Europe, 2005 - 2015 ($US) 486
  • Figure 9-8: Drivers and Limiters, Platelet and Bone Marrow Concentration Market, Europe, 2005 - 2015 488
  • Figure 9-9: Leading Competitors, Platelet and Bone Marrow Concentration Market, Europe, 2008 489

ABBREVIATIONS 491

APPENDIX 1: JOINT RECONSTRUCTION PROCEDURES 492

  • Figure 11-1: Combined Joint Revision Procedures, Europe, 2005 - 2015 493
  • Figure 11-2: Hip Joint Revision Procedures, Europe, 2005 - 2015 494
  • Figure 11-3: Knee Joint Revision Procedures, Europe, 2005 - 2015 495

LIST OF CHARTS

EXECUTIVE SUMMARY 1

  • Chart 1-1: Total Biomaterial Market, Europe, 2005 - 2015 (€) 1
  • Chart 1-2: Autograft Procedures, Europe, 2008 2
  • Chart 1-3: BGS Units, Used and Unused, Europe, 2005 - 2015 3
  • Chart 1-4: Units Implanted, Bone Graft Substitute Market, Europe, 2008 4
  • Chart 1-5: Hyaluronic Viscosupplementation Procedures, Europe, 2005 - 2015 5
  • Chart 1-6: Autologous Chondrocyte Implantation Market, Europe, 2005 - 2015 (€) 6
  • Chart 1-7: Leading Competitors, Orthopedic Biomaterial Market, Europe, 2008 8

RESEARCH METHODOLOGY 9

OVERVIEW OF EUROPEAN ORTHOPEDIC BIOMATERIALS 20

  • Chart 3-1: Total European Orthopedic Biomaterial Market, Europe, 2005 - 2015 (€) 24
  • Chart 3-2: Total European Orthopedic Biomaterial Market by Segment, Europe, 2008 26
  • Chart 3-3: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2008 32

COUNTRY PROFILES 35

  • Chart 4-1: German Price Index, GDP per Capita, and Population, 2008 36
  • Chart 4-2: French Price Index, GDP per Capita, and Population, 2008 37
  • Chart 4-3: U.K. Price Index, GDP per Capita, and Population, 2008 38
  • Chart 4-4: Spanish Price Index, GDP per Capita, and Population, 2008 39
  • Chart 4-5: Italian Price Index, GDP per Capita, and Population, 2008 40
  • Chart 4-6: Beneluxian Price Index, GDP per Capita, and Population, 2008 41
  • Chart 4-7: Scandinavian Price Index, GDP per Capita, and Population, 2008 42
  • Chart 4-8: Swiss Price Index, GDP per Capita, and Population, 2008 43
  • Chart 4-9: Austrian Price Index, GDP per Capita, and Population, 2008 44
  • Chart 4-10: Portuguese Price Index, GDP per Capita, and Population, 2008 45
  • Chart 4-11: Greek Price Index, GDP per Capita, and Population, 2008 46
  • Chart 4-12: Bone Graft Substitute Procedures per Population, Europe, 2008 47

BONE GRAFT SUBSTITUTE MARKET 48

  • Chart 5-1: Total Bone Graft Substitute Market, Europe, 2005 - 2015 (€) 54
  • Chart 5-2: Total Market Value by Country, Europe, 2008 (€) 56
  • Chart 5-3: Total Bone Graft Substitute Procedures by Country, Europe, 2008 (€) 57
  • Chart 5-4: Total Bone Graft Substitute Market, Germany, 2005 - 2015 (€) 94
  • Chart 5-5: Total Bone Graft Substitute Market, France, 2005 - 2015 (€) 126
  • Chart 5-6: Total Bone Graft Substitute Market, U.K., 2005 - 2015 (€) 158
  • Chart 5-7: Total Bone Graft Substitute Market, Spain, 2005 - 2015 (€) 190
  • Chart 5-8: Total Bone Graft Substitute Market, Italy, 2005 - 2015 (€) 222
  • Chart 5-9: Total Bone Graft Substitute Market, Benelux, 2005 - 2015 (€) 254
  • Chart 5-10: Total Bone Graft Substitute Market, Scandinavia, 2005 - 2015 (€) 286
  • Chart 5-11: Total Bone Graft Substitute Market, Switzerland, 2005 - 2015 (€) 319
  • Chart 5-12: Total Bone Graft Substitute Market, Austria, 2005 - 2015 (€) 351
  • Chart 5-13: Total Bone Graft Substitute Market, Portugal, 2005 - 2015 (€) 383
  • Chart 5-14: Total Bone Graft Substitute Market, Greece, 2005 - 2015 (€) 415

BMP GROWTH FACTOR MARKET 445

  • Chart 6-1: Orthopedic Growth Factor Market, Europe, 2005 - 2015 (€) 447
  • Chart 6-2: Leading Competitors, Orthopedic Growth Factor Market, Europe, 2008 452

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 454

  • Chart 7-1: Total Hyaluronic Acid Viscosupplement Market, Europe, 2005 - 2015456
  • Chart 7-2: Total Single-Cycle Hyaluronic Acid Viscosupplement Market, Europe, 2005 - 2015 458
  • Chart 7-3: Total Three-Cycle Hyaluronic Acid Viscosupplement Market, Europe, 2005 - 2015 460
  • Chart 7-4: Total Five-Cycle Hyaluronic Acid Viscosupplement Market, Europe, 2005 - 2015 462
  • Chart 7-5 Hyaluronic Acid Viscosupplementation Injections per Country, Europe, 2008 464
  • Chart 7-6: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Europe, 2008 469

AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET 470

  • Chart 8-1: ACI Market, Europe, 2005 - 2015 (€) 472

PLATELET AND BONE MARROW CONCENTRATION MARKET 478

  • Chart 9-1: Figure 9-1: Total Cell Concentration Market, Europe, 2005 - 2015 (€)481
  • Chart 9-2: Platelet Concentration Market, Europe, 2005 - 2015 (€) 483
  • Chart 9-3: Bone Marrow Concentration Market, Europe, 2005 - 2015 (€) 485
  • Chart 9-4: Leading Competitors, Platelet and Bone Marrow Concentration Market, Europe, 2008 490

ABBREVIATIONS 491

APPENDIX 1: JOINT RECONSTRUCTION PROCEDURES 492
相關報告
亞太地區的牙科用骨移植片代替物・其他生技材料市場：2009年（日本・韓國・澳洲） 全球生物相容性材料市場 膠原蛋白及玻尿酸基礎之生物材料：世界趨勢 亞太地區整形外科用生物材料市場：2009年 歐洲之牙科骨移植片替代物・其他生物材料市場：2009年
Top